Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EKO SENSORA: Detecting Clinically Significant Murmurs

NCT: NCT06155643 · RECRUITING

NCT IDNCT06155643
StatusRECRUITING
Start Date2023-10-26
Completion2027-07-26
SponsorCorewell Health South (OTHER)
First posted
Last updated

Brief Summary

The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.

Frequently Asked Questions

What is EKO SENSORA: Detecting Clinically Significant Murmurs?

EKO SENSORA: Detecting Clinically Significant Murmurs is a clinical trial registered under NCT06155643. Current status: RECRUITING.

What is the status of NCT06155643?

The current status of NCT06155643 (EKO SENSORA: Detecting Clinically Significant Murmurs) is: RECRUITING.

When did EKO SENSORA: Detecting Clinically Significant Murmurs start?

EKO SENSORA: Detecting Clinically Significant Murmurs started on 2023-10-26.

Related Devices

K233609CORE 500 Digital StethoscopeEko Health, Inc. K261694CORE 300 Digital StethoscopeEko Health, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑